journal article·2021-04-01Open access

Multiplexing physical stimulation on single human induced pluripotent stem cell-derived cardiomyocytes for phenotype modulation

Worrapong Kit-Anan, Manuel M Mazo, Brian X Wang, Vincent Leonardo, Isaac J Pence, Sahana Gopal, Amy Gelmi, Anika Nagelkerke, Michele Becce, Ciro Chiappini, Sian E Harding, Cesare M Terracciano, Molly M Stevens

Biofabrication· Volume 13· Issue 2

Abstract

Abstract Traditional in vitro bioengineering approaches whereby only individual biophysical cues are manipulated at any one time are highly inefficient, falling short when recapitulating the complexity of the cardiac environment. Multiple biophysical cues are present in the native myocardial niche and are essential during development, as well as in maintenance of adult cardiomyocyte (CM) phenotype in both health and disease. This study establishes a novel biofabrication workflow to study and manipulate hiPSC-CMs and to understand how these cells respond to a multiplexed biophysical environment, namely 3D shape and substrate stiffness, at a single cell level. Silicon masters were fabricated and developed to generate inverse patterns of the desired 3D shapes in bas relief, which then were used to mold the designed microwell arrays into a hydrogel. Polyacrylamide (PAAm) was modified with the incorporation of acrylic acid to provide a carboxylic group conjugation site for adhesion motifs, without compromising capacity to modulate stiffness. In this manner, two individual parameters can be finely tuned independently within the hydrogel: the shape of the 3D microwell and its stiffness. The design allows the platform to isolate single hiPSC-CMs to study solely biophysical cues in the absence of cell-cell physical interaction. Under physiologic-like physical conditions (3D shape resembling that of adult CM and 9.83 kPa substrate stiffness that mimics muscle stiffness), isolated single hiPSC-CMs exhibit increased Cx-43 density, cell membrane stiffness and calcium transient amplitude; co-expression of the subpopulation-related MYL2-MYL7 proteins; and higher anisotropism than cells in pathologic-like conditions (flat surface and 112 kPa substrate stiffness). This demonstrates that supplying a physiologic or pathologic microenvironment to an isolated single hiPSC-CM in the absence of any physical cell-to-cell communication in this biofabricated platform leads to a significantly different set of cellular features, thus presenting a differential phenotype. Importantly, this demonstrates the high plasticity of hiPSC-CMs even in isolation. The ability of multiple biophysical cues to significantly influence isolated single hiPSC-CM phenotype and functionality highlights the importance of fine-tuning such cues for specific applications. This has the potential to produce more fit-for-purpose hiPSC-CMs. Further understanding of human cardiac development is enabled by the robust, versatile and reproducible biofabrication techniques applied here. We envision that this system could be easily applied to other tissues and cell types where the influence of cellular shape and stiffness of the surrounding environment is hypothesized to play an important role in physiology.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Pluripotent Stem Cells Research · Neuroscience and Neural Engineering · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (94)

Show source-provided references
1. Heart disease and stroke statistics—2016 update10.1161/CIR.0000000000000350 ↗
2. Cardiac regenerative capacity and mechanisms10.1146/annurev-cellbio-101011-155739 ↗
3. Induction of pluripotent stem cells from adult human fibroblasts by defined factors10.1016/j.cell.2007.11.019 ↗
4. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions10.1038/nprot.2012.150 ↗
5. Many cells make life work—multicellularity in stem cell-based cardiac disease modelling10.3390/ijms19113361 ↗
6. Cardiopoietic factors10.1161/CIRCRESAHA.110.223792 ↗
7. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness10.1073/pnas.1508073112 ↗
8. Sarcomere alignment is regulated by myocyte shape10.1002/cm.20290 ↗
9. The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibres10.1113/jphysiol.1979.sp012804 ↗
10. Cardiac function and modulation of sarcomeric function by length10.1093/cvr/cvm099 ↗
11. Biology of the cardiac myocyte in heart disease10.1091/mbc.E16-01-0038 ↗
12. Effect of mechanical loading on three-dimensional cultures of ESC-derived CMs10.1089/ten.a.2007.0092 ↗
13. Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy10.1371/journal.pone.0194909 ↗
14. Cooperative coupling of cell-matrix and cell–cell adhesions in cardiac muscle10.1073/pnas.1203007109 ↗
15. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients10.1161/res.123.suppl_1.243 ↗
16. Surface chemistry and microtopography of parylene c films control the morphology and microtubule density of cardiac myocytes10.1089/ten.tec.2015.0581 ↗
17. Substrate stiffness, cell anisotropy, and cell-cell contact contribute to enhanced structural and calcium handling properties of human embryonic stem cell-derived cardiomyocytes10.1021/acsbiomaterials.8b01256 ↗
18. Engineering of mature human induced pluripotent stem cell-derived cardiomyocytes using substrates with multiscale topography10.1002/adfm.201707378 ↗
19. Matrix elasticity regulates the optimal cardiac myocyte shape for contractility10.1152/ajpheart.00799.2013 ↗
20. Cardiomyocytes sense matrix rigidity through a combination of muscle and non-muscle myosin contractions10.1016/j.devcel.2017.12.024 ↗
21. Hydrogels with time-dependent material properties enhance cardiomyocyte differentiation in vitro10.1016/j.biomaterials.2010.10.020 ↗
22. Substrate stiffness increases twitch power of neonatal cardiomyocytes in correlation with changes in myofibril structure and intracellular calcium10.1016/j.bpj.2011.09.057 ↗
23. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes10.1529/biophysj.107.124545 ↗
24. Cardiac myocyte force development during differentiation and maturation10.1111/j.1749-6632.2009.05091.x ↗
25. Micropatterning alginate substrates for in vitro cardiovascular muscle on a chip10.1002/adfm.201203319 ↗
26. Rapid 3D bioprinting of in vitro cardiac tissue models using human embryonic stem cell-derived cardiomyocytes10.1016/j.bprint.2019.e00040 ↗
27. Remote magnetic nanoparticle manipulation enables the dynamic patterning of cardiac tissues10.1002/adma.201904598 ↗
28. Elastic serum-albumin based hydrogels: mechanism of formation and application in cardiac tissue engineering10.1039/C8TB01014E ↗
29. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues10.1089/ten.tea.2011.0341 ↗
30. Substrate stiffness and composition specifically direct differentiation of induced pluripotent stem cells10.1089/ten.tea.2014.0251 ↗
31. A novel technique for micro-patterning proteins and cells on polyacrylamide gels10.1039/c2sm25533b ↗
32. Multimaterial polyacrylamide: fabrication with electrohydrodynamic jet printing, applications, and modeling10.1088/1758-5082/6/3/035018 ↗
33. Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes10.1038/nmeth.2524 ↗
34. Effect of patterned polyacrylamide hydrogel on morphology and orientation of cultured NRVMs10.1038/s41598-018-30360-6 ↗
35. Preparation of hydrogel substrates with tunable mechanical properties10.1002/0471143030.cb1016s47 ↗
36. Patterned hydrogel substrates for cell culture with electrohydrodynamic jet printing10.1002/mabi.201100004 ↗
37. A method for the generation of single contracting human-induced pluripotent stem cell-derived cardiomyocytes10.1161/CIRCRESAHA.115.307580 ↗
38. Integrated analysis of contractile kinetics, force generation, and electrical activity in single human stem cell-derived cardiomyocytes10.1016/j.stemcr.2015.10.017 ↗
39. Geometric microenvironment directs cell morphology on topographically patterned hydrogel substrates10.1016/j.actbio.2010.03.041 ↗
40. Amine coupling through EDC/NHS: a practical approach10.1007/978-1-60761-670-2_3 ↗
41. Chemically defined generation of human cardiomyocytes10.1038/nmeth.2999 ↗
42. AtomicJ: an open source software for analysis of force curves10.1063/1.4881683 ↗
43. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy10.1161/01.CIR.86.2.426 ↗
44. Transverse shape characteristics of cardiac myocytes from rats and humans
45. Histologically measured cardiomyocyte hypertrophy correlates with body height as strongly as with body mass index10.4061/2011/658958 ↗
46. The extracellular matrix in myocardial injury, repair, and remodeling10.1172/JCI87491 ↗
47. Myocardial stiffness evaluation using noninvasive shear wave imaging in healthy and hypertrophic cardiomyopathic adults
48. TNNI1, TNNI2 and TNNI3: evolution, regulation, and protein structure–function relationships10.1016/j.gene.2015.10.052 ↗
49. Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes10.1016/j.stemcr.2014.07.012 ↗
50. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue10.1093/clinchem/41.12.1710 ↗
51. The frank-starling mechanism in vertebrate cardiac myocytes10.1242/jeb.003145 ↗
52. Enhancement of gap junction function during acute myocardial infarction modifies healing and reduces late ventricular arrhythmia susceptibility10.1016/j.jacep.2016.03.007 ↗
53. Concise review: criteria for chamber-specific categorization of human cardiac myocytes derived from pluripotent stem cells10.1002/stem.2649 ↗
54. Advanced maturation of human cardiac tissue grown from pluripotent stem cells10.1038/s41586-018-0016-3 ↗
55. Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair10.1161/CIRCULATIONAHA.116.024145 ↗
56. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells10.1089/scd.2012.0490 ↗
57. Cell-surface marker signature for enrichment of ventricular cardiomyocytes derived from human embryonic stem cells10.1016/j.stemcr.2018.07.007 ↗
58. Patterning the heart, a template for human cardiomyocyte development10.1002/dvdy.20830 ↗
59. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion10.1002/cm.20041 ↗
60. Large-scale patterning of single cells and cell clusters in hydrogels10.1038/s41598-018-21989-4 ↗
61. Patterned microwell arrays for single-cell analysis and drug screening
62. Myofibrillar architecture in engineered cardiac myocytes10.1161/CIRCRESAHA.108.182469 ↗
63. Control of myocyte remodeling in vitro with engineered substrates10.1007/s11626-009-9182-9 ↗
64. Myocyte shape regulates lateral registry of sarcomeres and contractility10.1016/j.ajpath.2012.08.045 ↗
65. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating10.1242/jcs.029678 ↗
66. Coupling primary and stem cell–derived cardiomyocytes in an in vitro model of cardiac cell therapy10.1083/jcb.201508026 ↗
67. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells10.1016/j.biomaterials.2012.11.055 ↗
68. Biorealistic cardiac cell culture platforms with integrated monitoring of extracellular action potentials10.1038/srep11067 ↗
69. Extracellular matrix stiffness affects contractility in adult rat cardiomyocytes: implications for dynamic nitric oxide signalling and calcium handling10.1113/JP274787 ↗
70. Substrate stiffness modulates gene expression and phenotype in neonatal cardiomyocytes in vitro10.1089/ten.tea.2011.0707 ↗
71. In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction10.1016/j.actbio.2019.05.064 ↗
72. Mechanisms of the frank-starling law of the heart: the beat goes on10.1529/biophysj.107.117200 ↗
73. Review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes10.3389/fcell.2020.00178 ↗
74. Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform10.1016/j.bbamcr.2015.10.014 ↗
75. A practical guide to hydrogels for cell culture10.1038/nmeth.3839 ↗
76. Bulk and micropatterned conjugation of extracellular matrix proteins to characterized polyacrylamide substrates for cell mechanotransduction assays10.2144/000112026 ↗
77. Characterizing and patterning polyacrylamide substrates functionalized with n-hydroxysuccinimide10.1007/s12195-013-0288-5 ↗
78. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes10.1161/CIRCRESAHA.114.300558 ↗
79. Comparative gene expression analyses reveal distinct molecular signatures between differentially reprogrammed cardiomyocytes10.1016/j.celrep.2017.09.005 ↗
80. Stability of adhesion clusters and cell reorientation under lateral cyclic tension10.1529/biophysj.108.131342 ↗
81. Dynamics of cellular reorientation on a substrate under biaxial cyclic stretches10.1021/acs.nanolett.5b02095 ↗
82. The expression, phosphorylation, and localization of connexin 43 and gap-junctional intercellular communication during the establishment of a synchronized contraction of cultured neonatal rat cardiac myocytes10.1006/excr.1994.1154 ↗
83. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro—Correlation between contraction force and electrophysiology10.1016/j.biomaterials.2015.01.067 ↗
84. Biophysical study of human induced pluripotent stem cell-derived cardiomyocyte structural maturation during long-term culture10.1016/j.bbrc.2018.03.198 ↗
85. Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes10.4252/wjsc.v11.i1.33 ↗
86. CRISPR/Cas9 editing in human pluripotent stemcell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy10.1093/eurheartj/ehy249 ↗
87. Novel adult-onset systolic cardiomyopathy due to MYH7 E848G mutation in patient-derived induced pluripotent stem cells10.1016/j.jacbts.2018.08.008 ↗
88. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes10.1016/j.bbamcr.2015.11.005 ↗
89. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes10.1016/j.scr.2013.09.003 ↗
90. Developmental expression and cardiac transcriptional regulation of Myh7b, a third myosin heavy chain in the vertebrate heart10.1002/cm.21029 ↗
91. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses10.1038/nrg3185 ↗
92. Human pluripotent stem cell-derived cardiovascular cells: from developmental biology to therapeutic applications10.1016/j.stem.2019.07.010 ↗
93. Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes10.1016/j.carpath.2012.10.003 ↗
94. A cardiomyocyte show of force: A fluorescent alpha-actinin reporter line sheds light on human cardiomyocyte contractility versus substrate stiffness10.1016/j.yjmcc.2020.03.008 ↗